Cardiologist agrees to $5.8M settlement for implanting dozens of unnecessary stents |
Energy drink consumption triggers high BP, electrical abnormalities in heart |
Survey: Nearly half of hypertensives unworried about future CV events |
Proton pump inhibitors linked to fatal cases of CVD, CKD, stomach cancer |
FDA fast-tracks new CV indication for Vascepa |
Ultra-processed foods threaten CV health in Western countries |
Fasting before cholesterol labs is futile, researchers say |
COAPT: Patients with HF, mitral regurgitation see better health outcomes with TMVR |
Heart attack victims wait an average of 3 hours to get help—here’s why |
AFib market expected to reach $14.7B by 2026 |
Some e-cig flavors could be more toxic than others |
Millennials less heart-healthy than Gen Xers at the same age |
Some Canadians waiting more than a year for elective echos |
Fertility treatment linked to peripartum cardiomyopathy |
Immigrant with heart failure, CAD deported without adequate access to healthcare |
ACC names 1st-ever director of diversity and inclusion |
Veterans with PTSD, depression more likely to participate in cardiac rehab |
1st live transmission of robotic PCI performed in Europe |
Women less likely to be resuscitated than men during OHCA |
Andrea Russo inducted as HRS president |
Study suggests MRI should be standard practice for NSTEMI diagnosis, treatment |
More than ⅔ of cardiovascular RCT reports skew language to reflect better outcomes |
Orsiro achieves lower target lesion failure, revascularization than thicker stents |
New guidelines redefine cardiogenic shock |
Abiomed’s Impella RP system is safe, FDA says |
Antibacterial envelope cuts risk of CIED infection by 40% |
How to alleviate patient anxiety about ICDs |
Abbott’s tricuspid valve repair system finds success in TRILUMINATE study |
Algorithm optimizes catheter ablation in AFib patients |
Dabigatran no more effective than aspirin for recurrent stroke prevention |
For teens, being overweight is just as risky as being obese |
Grapefruit juice prolongs patients’ QT interval |
Myocardial injury commonly miscoded as type 2 MI |
Early gastric bypass improves odds of diabetes remission in teens |
T-cells in arterial plaque could signal stroke risk |
FDA approves 1st anticoagulant for use in pediatric patients |
ICDs are underused in clinical practice—especially in women and minorities |
More than ⅓ of statin patients fail to achieve healthy LDL-C |
First personal 6-lead ECG cleared for sale in US |
Arthritic pain reliever glucosamine cuts risk of CVD death by 22% |
Federal judge: Illegal actions by FDA fueled e-cig epidemic |
New rule allows physicians to refuse care on grounds of religious, moral beliefs |
Azithromycin ‘Z-packs’ tied to potentially fatal arrhythmia |
Generic equivalent of Pfizer hypertension drug approved |
Risk of low-dose aspirin outweighs benefit in general population |
How AI could prevent unnecessary testing in patients with chest pain |
CV deaths in the UK trending up for 1st time in 50 years |
HRS releases consensus statement on arrhythmogenic cardiomyopathy: 5 things to know |
Algorithm tops physicians in predicting heart attacks, death |
Bioengineered blood vessels could replace vasculature damaged by renal failure, CVD |
Researchers developing AI-powered ‘smart ring’ to detect AFib |
How cardiologists reacted to the rapid rise and fall of BVS |
Stop the Bleeding: Hemorrhagic Complications Gain Ground on Ischemia in Treating Patients with Arrhythmia |
The Opioid Crisis May Be Coming to Your Cardiology Practice |
Challenges of Infective Endocarditis: The Opioid Crisis Hits Home & Cardiologists Can’t Go It Alone |
From Concept to Clearance: Why It’s So Expensive to Develop New CV Drugs |
Going the Distance: Is Telestenting a New Path for PCI? |
‘Really Not Close’: TAVR Trumps SAVR in Two Trials of Low-risk Patients |
Positive Projections: TAVR/TMVR Market Likely to Double by 2023 |
Making the Case for Cardiac PET: Before Buying in, Evaluate Clinical & Business Considerations |
BioCardia receives clearance for AVANCE steerable catheter introducers |
Study reveals patients don’t know much about their heart implants—but they want to |
Antiglycemic agent tied to 55 cases of life-threatening gangrene in diabetics |
More young people in the US are dying from HF-related CVD |
CVD in pregnancy the leading cause of death among US mothers |
Diabetic ketoacidosis more widespread in the US than Canada |
UGA researchers find 27 new metabolites tied to arterial stiffness |
FDA: Certain Medtronic pacemaker, CRT-P batteries can fail without warning |
CRT vs. RV pacing: Which is better for HFpEF patients? |
Preemie heart damage could be reversed with exercise in young adulthood |
Arsenic in drinking water linked to LV thickening, hypertrophy |
Biotech startup aims to eradicate CAD with gene editing |
FDA OKs Pfizer’s tafamidis to treat cardiac amyloidosis |
Migraine drug shows no increase in CV outcomes |
ARB update: Vivimed issues 19-lot recall of losartan |
Weighing the plausibility of a genetic test for predicting obesity |
Prolonged exposure to low-dose radiation elevates risk of hypertension |
Unnecessary procedures cost Kentucky cardiologist $1M, 5 years in prison |
Oral infections during childhood linked to CVD later in life |
CABG trumps PCI in multivessel CAD patients |
Live in Las Vegas: SCAI.19 Expands Focus on Live Cases |
AFib gadget packs BP monitor, ECG into singular device |
STEMI DTU trial greenlighted by the FDA |
AHA backs federal efforts to raise tobacco sale age to 21 |
Sex-specific VIRGO taxonomy better classifies women with MI |
Physicians often overlook statin guidelines for ASCVD patients |
Losartan recall grows by another 35 lots |
FDA clears world’s 1st active-fixation left heart lead |
Viagra-like sex drug also effective as HF therapy |